|
|
Volumn 30, Issue 4, 2002, Pages 751-754
|
|
Design of therapeutic chelating agents
|
|
Author keywords
Iron complexes; Ligands; Orally active
|
|
Indexed keywords
DEFERASIROX;
DEFERIPRONE;
IRON CHELATING AGENT;
KETONE DERIVATIVE;
LIGAND;
UNCLASSIFIED DRUG;
BINDING AFFINITY;
BLOOD BRAIN BARRIER;
CALCULATION;
COMPLEX FORMATION;
CONFERENCE PAPER;
DRUG ABSORPTION;
DRUG BINDING;
DRUG BIOAVAILABILITY;
DRUG DESIGN;
DRUG DISPOSITION;
DRUG EFFICACY;
DRUG HALF LIFE;
DRUG PENETRATION;
DRUG SELECTIVITY;
DRUG STABILITY;
ENZYME INHIBITION;
HUMAN;
HYDROPHILICITY;
IRON CHELATION;
LIPOPHILICITY;
MOLECULAR WEIGHT;
OXIDATION REDUCTION REACTION;
PARTITION COEFFICIENT;
PRIORITY JOURNAL;
THERMODYNAMICS;
THERMOSTABILITY;
BIOLOGICAL AVAILABILITY;
CHELATING AGENTS;
DRUG DESIGN;
HUMANS;
IRON CHELATING AGENTS;
LIGANDS;
MOLECULAR WEIGHT;
THERMODYNAMICS;
TISSUE DISTRIBUTION;
|
|
EID: 0036669925
PISSN: 03005127
EISSN: None
Source Type: Journal
DOI: 10.1042/BST0300751 Document Type: Conference Paper |
|
Times cited : (13)
|
|
References (14)
|
